Translational Medicine
Open Access

Department of Pharmacy, Hyderabad, India

Publications

• Short Communication   
  An Overview on SARSCoV-2
  Author(s): Jaya Keerthi*
  
  A Novel Covid (named 2019-nCoV) was accounted for in December 2019 from genomic screening of clinical examples from patients with viral pneumonia in Wuhan, China. The essential viral pneumonia patients were discovered to be epidemiologically connected to the Huanan fish market in Wuhan City, Hubei Province, China, where other non-oceanic creatures, for example, bats, pangolins and bunnies, were at a bargain before the episode. Using cutting edge sequencing, another, human tainting Covid, temporarily called 2019 novel Covid (2019-nCoV), was recognized. Thusly, on February 11, 2020, episode or illness recently known as "novel Covid" or 2019-nCoV was formally renamed as C-O-V-I-D-19 or COVID-19 and causal infection was named as “Severe acute respiratory syndrome-related coronavirus 2” or SARSCoV-2.. View More»
  DOI: 10.36648/2161-1025.21.11.218

  Abstract HTML PDF